EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells

Luca Salhöfer, Ulrike B Hendgen-Cotta, Joachim Fandrey iD, Timm Schreiber iD, Tristan Leu

Experimental Physiology · 2026-04 · 111 (4) · 2058-2072

DOI: 10.1113/ep093391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 13.03.2026. Verfasst von Luca Salhöfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, University Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Myocardial Infarction, Prolyl-Hydroxylase Inhibitors, Myocardial Reperfusion Injury, Myocytes, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiosphere‐derived cells (CDCs) are a promising in vitro model for studying myocardial ischaemia–reperfusion (I–R) injury and testing potential therapeutic interventions. This study investigated the suitability of CDCs as a model for myocardial infarction (MI) and the effects of prolyl hydroxylase inhibitor (PHI) administration during reperfusion. CDCs were generated from neonatal mouse hearts and characterized by immunofluorescence, revealing a heterogeneous mixture of cardiomyocytes, smooth muscle cells, endothelial cells, and stem cells. The CDCs were subjected to oxygen–glucose deprivation (OGD) followed by reperfusion with or without the PHI dimethyloxalylglycine (DMOG). Cell viability, hypoxia‐inducible factor 1‐alpha (HIF‐1α) accumulation, and gene expression were analysed. The results showed that DMOG administration during reperfusion reduced lactate dehydrogenase release, indicating decreased cell death. HIF‐1α protein levels increased during OGD and were further stabilized by DMOG during reperfusion. The expression of HIF‐1α target genes, such as vascular endothelial growth factor ( Vegfa ), and genes involved in regeneration and cardiac function, including connective tissue growth factor ( Ctgf ), cyclin D2 ( Ccnd2 ), and beta‐1 adrenergic receptor ( Adrb1 ), was modulated by OGD and DMOG treatment. Comparisons with an in vivo mouse I–R injury model revealed similarities in gene expression patterns. In conclusion, CDCs serve as an effective in vitro model for studying I–R injury, closely resembling the in vivo situation. Furthermore, PHI administration during reperfusion reduces cell death and modulates the expression of genes involved in cardioprotection and regeneration, highlighting the potential of PHIs as a therapeutic strategy for I–R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionProlyl-Hydroxylase InhibitorsMyocardial Reperfusion InjuryMyocytes, CardiacCardiotonic AgentsAnimalsHypoxia-Inducible Factor 1, alpha SubunitMiceAmino Acids, DicarboxylicCell SurvivalMice, Inbred C57BLCells, Cultured

Stichwörter der Autor:innen

HIFPHIcardiosphere‐derived cellsischaemiamyocardial infarction

Substanzen

Prolyl-Hydroxylase InhibitorsHypoxia-Inducible Factor 1, alpha SubunitAmino Acids, DicarboxylicCardiotonic Agentsoxalylglycine

Autor:innen und Institutionen

  • Institute of Physiology, University Duisburg-Essen, Essen, Germany.
  • Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Institute of Physiology and Pathophysiology, and Centre for Biomedical Education and Research (ZBAF), University of Witten/Herdecke, Witten, Germany.

ORCID-Profile: Joachim Fandrey, Timm Schreiber

Zitieren

APA

Salhöfer, L., Hendgen-Cotta, U. B., Fandrey, J., Schreiber, T., & Leu, T. (2026). Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells. Experimental Physiology, 111(4), 2058-2072. https://doi.org/10.1113/ep093391

Vancouver

Salhöfer L, Hendgen-Cotta UB, Fandrey J, Schreiber T, Leu T. Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells. Experimental Physiology. 2026;111(4):2058-2072. doi:10.1113/ep093391

BibTeX
@article{Salhfer2026,
  author = {Salhöfer, Luca and Hendgen-Cotta, Ulrike B and Fandrey, Joachim and Schreiber, Timm and Leu, Tristan},
  title = {Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells},
  journal = {Experimental Physiology},
  year = {2026},
  volume = {111},
  number = {4},
  pages = {2058--2072},
  doi = {10.1113/ep093391}
}
Kostenlos starten →